drugset / Trial / NCT03598348
Evaluate the Efficacy of Maintenance Treatment With Capecitabine Plus Apatinib in Advanced Gastric Cancer
RandomizedParallel-groupOpen-labelTreatment
Summary
This is a multicenter, randomized, controlled trial to evaluate the efficacy and safety of Maintenance Treatment with Capecitabine plus Apatinib, Apatinib and Observation after First-line XELOX/SOX chemotherapy for Patients with Advanced Gastric Cancer
Timeline
- Start
- 2018-01-16
- Primary completion
- 2020-01-16
- Completion
- 2020-10-16
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Capecitabine | Small molecule | 1000 mg/m2 | Oral |
| Subject | Rivoceranib | Small molecule | 250 mg | Oral |